Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf546 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Qizong Lao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Steroid 21-Hydroxylase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Context
Genetic testing for 21-hydroxylase deficiency (21OHD) is advantageous when hormonal testing is equivocal, to molecularly confirm diagnosis, and for genetic counseling.
Objective
To characterize the clinical and biochemical phenotype across the genotypic spectrum of 21OHD in a large cohort using updated genetic methodology.
Design
Retrospective study of 457 individuals with 21OHD enrolled in a Natural History Study at the National Institutes of Health Clinical Center.
Results
The majority (79%) were compound heterozygous, 46% with chimeric alleles/30-kb deletions including 2.6% with attenuated chimeras, 10.1% with CAH-X (33% with cardiac defects), and 3.7% with genotype-phenotype discordance. The most common mutations among individuals with salt-wasting, simple-virilizing, and nonclassic (NC) phenotypes were In2G, I172N, and V281L, respectively. Rare or novel mutations accounted for 4.3% alleles, 0.33% arose de novo. 17OHP levels at diagnosis varied by genotype group (Null > In2G > simple-virilizing genotypes > P30L > Other NC; P < .001); but maximum values obtained during clinical care over time were similar among all classic and among all NC genotypes. Individuals with P30L had higher 17OHP and lower cortisol at diagnosis compared to other NC genotypes (P < .001) and were more likely to have basal 17OHP >1000 ng/dL (P < .001). Individuals with cryptic NC CAH had lower 17OHP after cosyntropin stimulation compared to those with symptomatic NC CAH (P = .02).
Conclusion
A continuum of disease phenotypes exists with biochemical overlap that increases with age. Improving genotype accuracy to include chimera subtyping to identify attenuated chimeras and CAH-X and consideration of P30L as a unique group are important to guide genetic counseling and provide anticipatory guidance in disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.
- Division of Genetics and Metabolism, Children's National Hospital, Washington, DC 20010, USA.
- Department of Pediatrics and Orthopedics, George Washington University, Washington, DC 20052, USA.
- Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, USA.
ORCID-Profile: Qizong Lao, Sarah Kulkarni, Deepika Burkardt, Deborah P Merke
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Lao, Q., Schulman, A., Kulkarni, S., Kollender, S., Bick, D., Moon, A., Burkardt, D., & Merke, D. P. (2026). Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf546
Vancouver
Lao Q, Schulman A, Kulkarni S, Kollender S, Bick D, Moon A, et al. Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf546
BibTeX
@article{Lao2026,
author = {Lao, Qizong and Schulman, Annie and Kulkarni, Sarah and Kollender, Sarah and Bick, Daniella and Moon, Amy and Burkardt, Deepika and Merke, Deborah P},
title = {Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf546}
}
EUVIMED